We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$165B
AUM Growth
-$22.2B
Cap. Flow
-$11.2B
Cap. Flow %
-6.82%
Top 10 Hldgs %
27.67%
Holding
6,926
New
1,006
Increased
1,821
Reduced
3,025
Closed
497

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$852M
2
MSFT icon
Microsoft
MSFT
+$575M
3
CVNA icon
Carvana
CVNA
+$540M
4
TGT icon
Target
TGT
+$430M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$376M

Sector Composition

Rank Sector Weight
1 Technology 12.49%
2 Financials 5.96%
3 Consumer Discretionary 5.3%
4 Healthcare 4.99%
5 Communication Services 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPTA
5601
Perpetua Resources
PPTA
$2.18B
$6K ﹤0.01%
1,419
-7,968
-85% -$31.9K
QMCO icon
5602
Quantum Corp
QMCO
$444M
$6K ﹤0.01%
128
-632
-83% -$46.3K
RANI icon
5603
Rani Therapeutics
RANI
$92.1M
$6K ﹤0.01%
422
-442
-51% -$7.33K
SHE icon
5604
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$323M
$6K ﹤0.01%
65
-232
-78% -$21.4K
STNE icon
5605
CALL
StoneCo
STNE
$2.71B
$6K ﹤0.01%
500
TDTT icon
5606
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
$6K ﹤0.01%
223
VTYX
5607
DELISTED
Ventyx Biosciences
VTYX
$6K ﹤0.01%
407
-2,419
-86% -$32.3K
WVE icon
5608
Wave Life Sciences
WVE
$1.13B
$6K ﹤0.01%
2,936
-11,447
-80% -$28K
ZEPP
5609
Zepp Health
ZEPP
$68M
$6K ﹤0.01%
551
-36
-6% -$581
FNA
5610
DELISTED
Paragon 28, Inc.
FNA
$6K ﹤0.01%
339
-2,054
-86% -$33.1K
GHSI
5611
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$6K ﹤0.01%
510
+138
+37% +$2.8K
CYT
5612
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$6K ﹤0.01%
1,480
-1,663
-53% -$9.47K
RAIN
5613
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$6K ﹤0.01%
1,277
-4,295
-77% -$34.4K
PRPC.WS
5614
CALL
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$6K ﹤0.01%
+9,197
New +$6.59K
LTRPA
5615
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$6K ﹤0.01%
2,772
-15,330
-85% -$32.5K
INFI
5616
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$6K ﹤0.01%
5,152
-19,621
-79% -$23.4K
HEXO
5617
DELISTED
HEXO Corp. Common Shares
HEXO
$6K ﹤0.01%
+668
New +$5.68K
TCRR
5618
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$6K ﹤0.01%
2,142
-6,734
-76% -$21.2K
CRZNW
5619
CALL
DELISTED
Corazon Capital V838 Monoceros Corp Warrant
CRZNW
$6K ﹤0.01%
+16,667
New +$8.43K
SCOBW
5620
CALL
DELISTED
ScION Tech Growth II Warrants
SCOBW
$6K ﹤0.01%
+19,989
New +$8.44K
HIIIW
5621
CALL
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$6K ﹤0.01%
+15,001
New +$7.5K
KIIIW
5622
CALL
DELISTED
Kismet Acquisition Three Corp. Warrant
KIIIW
$6K ﹤0.01%
+33,334
New +$11K
HTAQ.WS
5623
CALL
DELISTED
Hunt Companies Acquisition Corp. I Warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 per share
HTAQ.WS
$6K ﹤0.01%
+25,301
New +$8.22K
GBL
5624
DELISTED
GAMCO Investors, Inc.
GBL
$6K ﹤0.01%
265
-859
-76% -$19K
AMPE
5625
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$6K ﹤0.01%
46
-124
-73% -$18.1K

Similar funds

Citigroup's Q1 2022 Portfolio in Review

As of Q1 2022, Citigroup held 6,926 positions worth $165B, down 12% from $187B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citigroup withdrew a net $11.2B in Q1 2022, closing 497 positions and reducing 3,025 holdings. Its most notable exit was Xilinx Inc, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $126M.

  • Citigroup's largest Q1 2022 buy was ProShares UltraPro Short QQQ: 149,740 shares worth $126M.
  • Citigroup added most to iShares Russell 2000 ETF in Q1 2022, an estimated $654M increase.
  • Citigroup's biggest Q1 2022 reduction was Apple, cutting an estimated $852M.
  • Citigroup fully exited Xilinx Inc in Q1 2022, selling an estimated $235M.
  • Citigroup's ten largest holdings make up 28% of its $165B portfolio in Q1 2022.
  • Citigroup opened 1,006 new positions and closed 497 in Q1 2022.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $165B.

Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.